ZeOmega Releases Integrated Clinical Assessments That Promise to Improve the Quality of Care Management

Facilitating dynamic patient-centered conversations, improving the patient experience while following evidence-based care management guidelines

PLANO, Tex. May. 11, 2016 – ZeOmega®, a market leader in population health management solutions, has released its new and enhanced Clinical Assessment Protocols (CAPs), which among others, include integrated care management assessments to facilitate the holistic care of patients, particularly those with multiple conditions. Available in versions 5.6 and later of its Jiva™ platform, ZeOmega’s integrated assessments are whole-person centered, age group specific, and cover a wide range of conditions including psychosocial determinants of health that are often key to driving outcomes. The flexible, comprehensive, and cumulative assessments, developed based on NCQA and URAC measures and standards, are designed for use over multiple patient conversations across the continuum of care.

Built with Jiva’s Assessment Configuration Engine (ACE) module, ZeOmega’s out-of-the-box clinical assessments include evidence-based questions, branching logic, evidence-based references, and care plans tailored to the patient’s needs. Most assessment products on the market, including previous iterations of ZeOmega’s own solution, offer distinct protocols for different conditions. The challenge inherent in this approach is that it tends to limit the conversation to the condition at hand and potentially overlooks other vital health information the patient has to share.

“A patient’s health status rarely fits neatly into the framework of a condition-specific protocol,” said Dr. Christopher Mathews, CMO of ZeOmega. “Such assessments by nature tend to be more information-focused than patient-centered and can have an adverse effect on the patient experience.”

ZeOmega’s new integrated assessments, address this challenge by combining all clinically-relevant assessment content in a single protocol that the care manager can easily navigate, depending on where the patient conversation leads. This open-ended approach supports holistic, patient-centered interactions, allowing the complete picture of a patient’s health status to emerge over time.

“ZeOmega develops powerful modular solutions that facilitate among other things, the capture and effective management of health information,” Dr. Mathews continued. “By putting the patient at the center of the clinical assessment, we can improve the quality of the health information gathered, driving better outcomes and greater patient satisfaction.”

ZeOmega’s clinical team of physicians and nurses updates Jiva’s clinical assessments annually to reflect changes in best practices and regulatory requirements. Jiva versions that support the new integrated protocols come equipped with over 100 individual topics covering 6 primary groupings: adult, geriatric, pediatric, behavioral, wellness, and maternity. The integrated assessments, which capture the most common diseases and conditions in each of these categories, are optional.

About ZeOmega
Jiva™, the powerful population health platform from ZeOmega, delivers high-value, strategic solutions enabling payers and care-delivery organizations to improve individual health and provider performance. With deep domain expertise and a comprehensive understanding of complex population health challenges, ZeOmega serves as a true partner for clients, offering flexible deployment and delivery models that leverage an innovative platform designed to integrate workflow, analytics, content, and communication capabilities. By consistently meeting customer expectations and project benchmarks, ZeOmega has earned a reputation for responsiveness and reliability. For more information, visit www.zeomega.com.


Media Contact
Nancy Narraway
Vice President, Marketing

Access PDF of release.

Trademark Information: ZeOmega and Jiva are registered trademarks or trademarks of ZeOmega Inc. or its subsidiaries in the United States and other countries. Other marks or brands may be claimed as the property of others.